Vivek K. Narayan, MD, MS is an Associate Professor of Medicine specializing in Hematology-Oncology at the University of Pennsylvania's Perelman School of Medicine. He practices clinically at the Abramson Cancer Center within the Perelman Center for Advanced Medicine in Philadelphia, treating adult patients with genitourinary cancers. His educational background includes: Medical School: University of Virginia Residency: Hospital of the University of Pennsylvania Fellowship: Hospital of the University of Pennsylvania Dr. Narayan's research focuses on translational and clinical aspects of prostate cancer and renal cell carcinoma, with particular expertise in immunotherapy and cellular therapies. His laboratory work centers on the Prostate Cancer Cellular Therapy Program where he investigates novel CAR T-cell approaches and combination treatments for advanced disease. Analysis of his recent publications reveals strong emphasis on biomarker-driven therapies, treatment resistance mechanisms, and innovative clinical trial designs for genitourinary malignancies. Notable scientific contributions include: Phase 1 trial of PSMA-targeting TGFβ-insensitive CAR T-cells for metastatic prostate cancer (Nature Medicine 2022) Belzutifan for Von Hippel-Lindau disease-associated renal cell carcinoma (NEJM 2021) Leadership in the CheckMate 650 immunotherapy trial for prostate cancer (Cancer Cell 2020) As a clinician-scientist, Dr. Narayan maintains active involvement in patient care with a 5.0 average patient rating across 646 reviews, while directing translational research programs and mentoring through the Perelman School of Medicine. His work bridges basic science discoveries with clinical applications through numerous multi-institutional collaborations and clinical trials.
Jennifer Rose Gruhn is an Assistant Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen, working within the Molecular Aging Program. She is an active member of the Hoffmann Group, where she conducts research at the intersection of reproductive biology, chromosome dynamics, and aging. Dr. Gruhn's research focuses on understanding the fundamental mechanisms of human reproduction, particularly the high error rates in chromosome segregation during egg development. Her work addresses why human reproduction is particularly error-prone, with 50% of pre-implantation embryos showing developmental defects and 20%-85% of human eggs exhibiting aneuploidy (extra or missing chromosomes). Maternal age is identified as the strongest risk factor for aneuploidy, making reproductive aging a central focus of her investigations. Her recent publications reveal a consistent research trajectory examining the molecular basis of chromosomal abnormalities in human reproduction. Studies span from basic mechanisms of DNA repair and chromosome recombination to clinical applications in pregnancy loss diagnostics. Her work combines model organisms (mouse and yeast) with human egg and embryo research to investigate the DNA damage response and cell cycle proteins governing genetic changes in the germline. Dr. Gruhn has been involved in significant collaborative efforts, including the Copenhagen Pregnancy Loss Study (COPL), which has generated high-impact publications in journals like Nature and The Lancet. Her research has garnered substantial attention, with multiple papers picked up by news outlets, blogged about, and widely shared on social media platforms. As part of the Hoffmann Group, Dr. Gruhn contributes to advancing our understanding of the genetic changes that occur during human reproduction, with implications for both reproductive health and cancer research, as many of the same genes involved in maintaining germline genome stability are also implicated in oncogenesis.
Juan Francisco Lafuente Barquero serves as an Assistant Professor in the Andersen Group at the Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on the molecular mechanisms underlying biliary tract cancers, particularly cholangiocarcinoma and gallbladder cancer, with emphasis on genome instability, epigenetic regulation, and tumor microenvironment dynamics. His research interests span molecular oncology with specific focus on cancer epigenetics , genome instability mechanisms , cholangiocarcinoma pathogenesis , and tumor microenvironment interactions . His work integrates molecular biology, genomics, and cell biology approaches to understand the fundamental processes driving biliary tract cancers, with particular attention to transcription-associated genome instability, cytoskeletal dynamics in malignant transformation, and epigenetic remodeling during cancer progression. Analysis of his publication record reveals consistent contributions to high-impact hepatology and oncology journals including Journal of Hepatology , Trends in Cancer , and Molecular Genetics and Genomics . His research demonstrates evolving focus from fundamental genome stability mechanisms toward translational cancer biology, with increasing emphasis on molecular characterization of biliary tract cancers and identification of potential therapeutic targets. Recent work shows strong international collaboration networks spanning Europe and North America. No scientific awards were explicitly mentioned in the source material Dr. Lafuente Barquero actively collaborates within the Andersen Group led by Professor Jesper B. Andersen, contributing to multiple high-impact publications in liver cancer research. His work demonstrates significant grant-supported research activity through participation in international consortia including the CGR Exome Studies Group, with publications showing substantial citation impact (notably the 2020 Journal of Hepatology paper with 62 Scopus citations). While formal student mentorship isn't explicitly documented, his position as Assistant Professor suggests involvement in training graduate students and postdoctoral researchers within BRIC's academic environment. He operates within the Andersen Group at BRIC, a research environment focused on molecular cancer biology with particular expertise in liver cancers. The group maintains active collaborations with clinical researchers and international consortia, facilitating translational research from basic mechanisms to potential clinical applications in biliary tract cancers.
Simon Grund Sørensen is a Guest researcher at the Department of Cellular and Molecular Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen, affiliated with the Molecular Aging Program focused on molecular mechanisms of aging and age-related diseases. His research spans Cancer Genomics, DNA Repair, Aging Research, Molecular Biology, and Bioinformatics, investigating how DNA repair deficiencies drive characteristic mutational patterns across cancer types through genomic and computational approaches. This integrates molecular aging processes with cancer etiology to identify underlying genomic instability mechanisms. His 2023 eLife publication on pan-cancer DNA repair deficiencies exemplifies his work in genomic analysis, revealing how defective repair pathways generate mutation signatures across diverse cancers. This research bridges cancer genomics and aging biology by connecting DNA repair mechanisms to genome-wide mutational landscapes. No information is available regarding scientific awards, student advising, or research grants. Dr. Sørensen conducts research within the Molecular Aging Program, a collaborative initiative studying molecular aging pathways to develop interventions for age-related diseases like cancer.
Saskia Hoffmann is an Associate Professor at the Novo Nordisk Foundation Center for Protein Research (CPR) at the University of Copenhagen, where she leads research in the Mailand Group. She has held this position since October 2019 and maintains dual affiliation as both Associate Professor and Guest Researcher at CPR. Her academic credentials include: PhD in Biochemistry (2013-2016) from the University of Copenhagen, CPR, under Professor Niels Mailand with thesis on 'Functions of ubiquitin ligases in responses to replication stress and DNA damage' Master's in Biochemistry (2010-2012) from the University of Copenhagen supervised by Associate Professor Claus Storgaard Sørensen Bachelor's in Biochemistry (2007-2010) from the University of Leipzig, Germany, supervised by Professor Kurt Engeland Dr. Hoffmann's research program focuses on cellular responses to DNA damage and replication stress, with particular emphasis on understanding how cells counteract genotoxic insults to maintain genome stability. Her current work investigates the molecular link between human proteases and cellular surveillance pathways, revealing critical implications for human health and disease. Her research spans: Cell Biology mechanisms underlying genome maintenance Genome stability preservation pathways DNA Damage Response systems DNA Replication processes under stress conditions Protease functions in cellular surveillance Analysis of her publication record demonstrates a consistent research trajectory focused on DNA damage response mechanisms, protein modification systems (particularly ubiquitination and SUMOylation), and their roles in maintaining genome integrity. Her work frequently explores how defects in these pathways contribute to human diseases including genetic disorders and cancer, with several publications appearing in high-impact journals such as Nature Structural and Molecular Biology, Nature Communications, and Molecular Cell. Dr. Hoffmann has established herself as a significant contributor to the field of genome maintenance research, with her work on proteases and DNA damage response pathways opening new avenues for understanding disease mechanisms and potential therapeutic approaches.
Aaron Neiman is a Professor in the Department of Biochemistry and Cell Biology at Stony Brook University. His research focuses on the molecular mechanisms of spore formation in Saccharomyces cerevisiae , specifically prospore membrane development and spore wall assembly during yeast sporulation. Dr. Neiman's laboratory investigates fundamental cell biological processes including vesicle trafficking, membrane fusion, cytokinesis, signal transduction, and extracellular matrix assembly. His work employs yeast genetics and cell biology techniques to dissect membrane morphogenesis mechanisms during starvation-induced differentiation. His recent publications (2016-2021) reveal interdisciplinary research spanning yeast genetics, membrane biology, and human disease modeling. Key themes include Vps13-mediated membrane contact sites relevant to neurodegenerative disorders, spore wall assembly mechanisms, meiotic regulation pathways, and lipid metabolism in cell wall formation. This work bridges basic cell biology with translational implications for human health. Dr. Neiman has mentored 23 formal advisees throughout his career, including current lab members: one postdoctoral fellow (Jae-Sook Park), two graduate students (Kai Zhang, Greisly Nunez), and one master's student (Jiyao Chai). Past trainees comprise nine graduate students, six master's students, and four postdoctoral fellows who contributed to his prolific publication record. The Neiman lab operates from Life Sciences Building Room 332 at Stony Brook University, utilizing genetic, biochemical, and imaging approaches to study sporulation. The team maintains active research on membrane dynamics and cell wall biogenesis, with recent work focusing on Vps13 family proteins, spore maturation processes, and conserved mechanisms of cellular differentiation.
Miguel Garcia-Diaz is a Professor in the Department of Pharmacological Sciences at Stony Brook University, affiliated with the Consortium for Inter-disciplinary Environmental Research. His laboratory focuses on mitochondrial gene expression mechanisms and DNA synthesis/repair processes, with particular emphasis on how defects in these systems contribute to human diseases. Education: PhD, Universidad Autonoma, Madrid (Spain) Postdoctoral, National Institute of Environmental Health Sciences (Laboratory of Molecular Genetics and Laboratory of Structural Biology) Research Interests: Dr. Garcia-Diaz investigates mitochondrial transcription mechanisms including initiation regulation using in vitro systems combined with electron microscopy and x-ray scattering. His work also examines transcription termination via MTERF proteins' DNA-binding mechanisms and mitochondrial rRNA modifications essential for function. In DNA repair, his team studies specialized DNA polymerases that maintain genome stability under environmental stress. Laboratory: Leads the Mitochondrial Gene Expression and DNA Repair Research Group ( mgdlab.org ) at Basic Sciences Tower 7-122.
Dr Uda Ho is a Research Fellow at the School of Biomedical Sciences , The University of Queensland , with expertise spanning centrosome biology, DNA damage response, and inflammation. Her work intersects cancer development, cardiotoxicity, and developmental genetics. Bachelor of Science (The University of Queensland) Bachelor (Honours) (The University of Queensland) Doctor of Philosophy (The University of Queensland) Research interests include: Centrosome dynamics in cell differentiation Role of WDR62 in neurogenesis and cilia formation SMG1 in genomic stability and tumor suppression RNA metabolism in inflammatory regulation Cardiotoxicity mechanisms in cancer therapy Recent publications highlight work in: Trastuzumab-induced cardiotoxicity Centrosome reduction in cardiomyocytes WDR62's role in spermatogenesis and hippocampus development Microcephaly protein interactions DNA damage in hematopoietic cancers Grants and funding: Maternity Funding (2017-2018) from Advance Queensland Women's Academic Fund
John M. Abrams, Ph.D., is a Professor in the Department of Cell Biology at UT Southwestern Medical Center. He leads the Genetics, Development and Disease Graduate Program and directs the Abrams Lab, which explores molecular mechanisms of programmed cell death and tumor suppression through innovative genetic approaches in Drosophila , zebrafish, and mouse models. Cornell University (undergraduate, 1982) Stanford University (Ph.D., 1989) MIT (postdoctoral fellow, 1989-1994) Dr. Abrams' research focuses on the p53 regulatory network, transposon suppression, and genomic stability. His lab discovered that p53 tonically represses mobile genetic elements, suggesting a novel 'transposopathy' model for cancer development. Current projects examine stimulus-dependent p53 action in stem cells and interventions to mitigate transposopathies. Key findings include identifying the first global cell death defective mutation in Drosophila and the 'reaper' gene's role in apoptosis. His work on vector-targeted cytotoxins explores mosquito-specific insecticides for disease control, employing high-throughput screening platforms. Research Scholar Award - American Cancer Society Senior Scholar Award - Ellison Medical Foundation Dr. Abrams mentors graduate students and postdocs in the Abrams Lab. His team includes current members Po Chen, Annika Wylie, and 17 alumni, reflecting extensive contributions to training in cancer biology and cell death research.
Einar Hallberg is a Professor of Biochemistry at the Department of Biochemistry and Biophysics, Stockholm University . His research focuses on nuclear envelope proteins and their roles in Cell signaling Chromatin organization Mitotic machinery Neurodegenerative disease mechanisms The Hallberg group investigates how nuclear pore complexes (NPCs) and LINC complexes mediate mechanical signal transduction between cell surface and nucleus. Their work connects nuclear envelope proteomics to Laminopathies Cancer Alzheimer's disease Neuroblastoma models Recent publications highlight advanced imaging techniques like FRAP, FLIP and FRET to study Chromatin accessibility changes Caspase activation dynamics Mechanical signal transmission Membrane protein interactions through nuclear envelope structures. Scientific recognition includes Swedish Brain Foundation grants (2023) Extensive publication record in Cell Reports, Journal of Cell Science and Molecular Biology of the Cell
Lisa Schneper, PhD, is an Assistant Professor in the Department of Molecular and Precision Medicine. Her research spans epigenetics, genomics, and precision medicine, focusing on gene-environment interactions and molecular mechanisms in health and disease. Key research areas include epigenetic regulation of cognitive development, genome instability in viral oncogenesis, and stress response in microbial systems Active in translational research targeting epigenetic modifiers for retinal degeneration Contributing to UN Sustainable Development Goals through studies on health disparities Recent publications (2024-2025) demonstrate expertise in DNA methylation analysis, yeast transcriptomics, and epigenetic aging biomarkers. Collaborations span virology, ophthalmology, and social epidemiology fields.
Paolo Medini is an Associate Professor at Umeå University, affiliated with the Department of Medical and Translational Biology and the Center for Transdisciplinary AI. His research focuses on cortical microcircuits, sensory processing, and brain recovery mechanisms. Neuroscience Neurophysiology Cortical Plasticity Optogenetics His lab investigates how sensory information is processed by distinct cell types in cortical circuits and how these circuits adapt after brain lesions or sensory deprivations. Research spans both adaptive and maladaptive plasticity, aiming to differentiate molecular mechanisms for targeted interventions. Recent publications highlight applications of all-optical interrogation strategies and multisensory integration in the neocortex. Paolo Medini's group employs advanced techniques such as in vivo patch clamp recordings, two-photon calcium imaging, and optogenetics. They use genetically modified strains to study cell-type-specific responses and circuit reorganization post-lesion. Their work is critical for developing therapies in neurodegenerative diseases and cortical repair. Environmental enrichment for brain recovery (Nature Neuroscience) Cortical microcircuit organization (Neuron) Post-stroke plasticity (Journal of Physiology)
Dr. Elizabeth A Eklund is the Johanna Dobe Professor of Hematology and Oncology at Northwestern University Feinberg School of Medicine, where she serves as Professor in the Department of Medicine (Hematology and Oncology). She maintains hospital affiliations with Northwestern Memorial Hospital and Jesse Brown VA Medical Center, and is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Her educational background includes: MD from Rush Medical College (1983) Residency at Mayo Clinic-Rochester (1988) Fellowship at Indiana University Medical Center (1991) Board Certification in Internal Medicine and Hematology from the American Board of Internal Medicine Dr. Eklund's research focuses on leukemia, lymphoma, and myeloma with particular expertise in acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and Fanconi anemia. Her laboratory investigates molecular mechanisms of leukemogenesis, including the role of Triad1 protein, HOX gene expression, and signaling pathways in leukemia development and progression. She has made significant contributions to understanding how DNA repair defects in Fanconi anemia lead to bone marrow failure and leukemia. Her recent publications reveal a strong focus on molecular mechanisms in myeloid leukemias, with particular emphasis on protein regulation, stress responses, and signaling pathways. Her work bridges basic science discoveries with potential clinical applications, as evidenced by her active clinical trials program. Her scientific recognition includes: Leukemia and Lymphoma Society (LLS) Translational Research grant Research grant from the Fanconi Anemia Research Fund VA Merit Review award National Institutes of Health grant HL088747 Dr. Eklund actively mentors postdoctoral fellows and maintains productive research collaborations, as evidenced by her leadership of multiple clinical trials including NCI 12H13 studying molecular mechanisms of relapse in CML and NCI 15H01 investigating Triad1's role as a leukemia suppressor. Her work has been supported by substantial grant funding that enables translational research from bench to bedside. Her laboratory team focuses on understanding molecular pathways in leukemia development and identifying novel therapeutic targets, with particular emphasis on protein regulation, DNA repair mechanisms, and stem cell biology in the context of hematologic malignancies.
Markku Varjosalo is a Research Director at the Institute of Biotechnology, University of Helsinki, and a supervisor in the Doctoral Programmes in Biomedicine, Drug Research, and Integrative Life Science. His research focuses on biochemistry, molecular biology, and proteomics, with particular emphasis on gene fusions in cancer, immune response mechanisms, and protein interaction networks. Current projects include funding from Sigrid Jusélius Foundation (2025-2026) and Finnish Science Society (2025-2026) Active in Biocenter Finland infrastructure projects (2024-2025, 2024-2028) His recent publications highlight interdisciplinary work in proteomics, disease mechanisms, and systems biology approaches. He participates in organizing academic events like iCAN retreat 2024 and contributes to research infrastructure coordination through Instruct-ERIC. Funded by major Finnish research councils and foundations, his work spans cancer biology, cardiovascular genetics, and immunology.
Dr. Michael Edward Mitchell is a Professor of Surgery and Section Chief of Cardiothoracic Surgery at the Medical College of Wisconsin, where he also serves as Director of Regional Surgical Services and Director of the Pediatric Cardiothoracic Surgery Fellowship Program. He is affiliated with Children's Hospital of Wisconsin and holds adjunct appointments at the Milwaukee School of Engineering. Dr. Mitchell is a member of both the Cardiovascular Research Center and the Mellowes Center for Genomic Sciences and Precision Medicine. Professor, Surgery, Cardiothoracic Surgery, Medical College of Wisconsin Section Chief, Pediatrics, Cardiothoracic Surgery, Children's Hospital of Wisconsin Adjunct Professor, Electrical Engineering & Computer Science, Milwaukee School of Engineering Director, Regional Surgical Services, Children's Hospital of Wisconsin Program Director, ACGME Fellowship in Pediatric Cardiothoracic Surgery Dr. Mitchell received his A.B. in Chemistry from Princeton University (Cum Laude) in 1990 and his M.D. from Harvard Medical School (Magna Cum Laude) in 1995. He completed his surgical residency and cardiothoracic training at Brigham & Women's Hospital, followed by a fellowship in pediatric cardiac surgery at Children's Hospital of Philadelphia. In 2017, he enhanced his leadership skills through Harvard T.H. Chan School of Public Health's Leadership Development program. 1986-1990: A.B. (Chemistry), Princeton University (Cum Laude) 1990-1995: M.D., Harvard Medical School (Magna Cum Laude) 2017: Leadership Development for Physicians in Academic Health Centers, Harvard T.H. Chan School of Public Health Dr. Mitchell's research focuses on pediatric cardiothoracic surgery with particular emphasis on hypoplastic left heart syndrome (HLHS), cardiac transplantation, valve reconstruction, and the application of genomic sciences in congenital heart disease. His laboratory has made significant contributions to understanding the genetic basis of congenital heart defects, particularly through studies on MYH6 variants in HLHS. He has pioneered research on non-invasive monitoring of cardiac transplant rejection using cell-free DNA technology, with multiple recent publications validating this approach in both pediatric and adult patients. His work also includes innovative applications of 3D-bioprinting for creating patient-derived cardiac tissue models to study congenital heart disease. His research demonstrates a consistent trajectory toward integrating genomic medicine with traditional surgical approaches to improve outcomes for children with complex cardiac conditions. Dr. Mitchell has published over 140 articles in peer-reviewed journals, with recent work focusing on surgical outcomes for congenital heart disease, genetic contributions to cardiac malformations, and novel diagnostic approaches for transplant monitoring. His publication record shows consistent productivity with 15-20 publications annually, demonstrating ongoing innovation in both clinical practice and research methodology. Top Rated Doctor in Congenital Cardiac Surgery, Milwaukee Magazine (2013-2023) Health Care Champion for Surgical Treatment of Tracheal Agenesis, Milwaukee Business Journal (2021-2023) Advancements in Health Care/Health Care Heros, BizTimes (2014) Eureka Award, Milwaukee Business Journal (2015) As an educator and mentor, Dr. Mitchell directs the ACGME Fellowship in Pediatric Cardiothoracic Surgery and serves as course director for pediatric cardiothoracic surgical rotations for medical students and residents. He has supervised numerous trainees who have gone on to successful careers in congenital heart surgery. His laboratory maintains active collaborations with multiple institutions through participation in national research consortia and clinical trials, providing students with opportunities to engage in cutting-edge research with real-world clinical applications. Dr. Mitchell leads the Cardiovascular Research Center, which focuses on translating basic science discoveries into clinical applications for children with congenital heart disease. The center maintains strong collaborations with the Mellowes Center for Genomic Sciences and Precision Medicine, facilitating interdisciplinary approaches to understanding and treating complex cardiac conditions. His work on tracheal reconstruction has been particularly groundbreaking, establishing new surgical approaches for previously untreatable conditions.
